Recent

% | $
Quotes you view appear here for quick access.

Zillow Group, Inc. Message Board

crecy_war_knight 477 posts  |  Last Activity: 5 hours ago Member since: Jan 25, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    ACAD- where do we go from here.

    by crecy_war_knight Mar 12, 2015 1:11 PM
    crecy_war_knight crecy_war_knight Mar 13, 2015 3:31 PM Flag

    A new, great CEO will rocket this back up.

  • crecy_war_knight by crecy_war_knight Jan 7, 2015 2:48 PM Flag

    When these morons hate me and come up with their impostor names...it makes my day worth it. I love it and just place their butts on Ignore and never have to deal with them again. THEY HATE BEING IGNORED. Most of these fools like the Village Idiot are over extended shorts or dimwits who sold their shares and trying to buy them back. So to all have a great day, 2015 will be The year of Acadia Pharmaceuticals.

  • crecy_war_knight by crecy_war_knight Mar 12, 2015 1:11 PM Flag

    OK we have bumps in the road and surprise retirement of our CEO. I suspect due to the question of not meeting the Q1 2015 NDA filing date because manufacturing and production systems are not ready to meet FDA standards. I also believe behind the scenes there may have been disagreement regarding partnering to aid with the production of Pima. The drug has not changed, no issue there. So Uli is out making way for a possible PARTNERSHIP. I didn't sell when it fell to about $15 and not selling now. Pimavanserin is ONE OF A KIND, FIRST IN ITS CLASS drug to treat Parkinson's Disease Psychosis (PDP). And ACAD owns the World Wide Rights to it. The FDA has already reviewed the Phase3 research data and given ACAD thumbs up to proceed with the New Drug Application and has give Pima " Breakthrough Therapy Designation " . USA sales will be over 1.1 BILLION and European Union will be well over a Billion as well. There are several other ongoing studies...Review the catalyst list-

    1) Replacing the CEO with a new Great Leader who can led us to Drug Approval and move the company forward.
    2) Possible Partnership with a MAJOR drug company that will assure the NDA will meet and exceed all the FDA standards.
    3) 60 days for the FDA (Food and Drug Administration ) to accept the application. About Q1 2016.
    4) Upon potential acceptance, FDA could also grant priority review.
    5) With priority review, six months pdufa date (Prescription Drug User Fee Act ), without, 10 months.
    6) EU ( European Union ) filing 6- 9 months post FDA filing.
    7) ADP enrollment (019 study) complete by 2015 Q4 and data by about Q2 2016
    8) Schizophrenia maintenance trial to commence 2nd half of 2015.
    9) other, eg Autism.
    Dates are subject to debate & change and they do get delayed - this is not uncommon in the world of Biotech. You have to roll with the punches, but Never give up with a winner. Ok shorty, Go ahead...Make My Day.

  • crecy_war_knight by crecy_war_knight Mar 26, 2015 10:32 PM Flag

    We now have the BOD slot filled, Mr Soland, and most likely the short list for the CEO position is close to being completed. I would say a few more weeks for the new CEO to be announced. It won't be Davis. Pimavanserin is ONE OF A KIND, FIRST IN ITS CLASS drug to treat Parkinson's Disease Psychosis (PDP). And ACAD owns the World Wide Rights to it. The FDA has already reviewed the Phase3 research data and given ACAD thumbs up to proceed with the New Drug Application and has give Pima " Breakthrough Therapy Designation " USA sales will be over 1.1 BILLION and European Union will be well over a Billion as well. There are several other ongoing studies.. The manufacturing arm of the NDA is getting the close attention it should of had last year- it will take some time for new directors & CMO 's to get the systems ready & on line for the FDA evaluations. ..Review the catalyst list-

    1) Replacing the CEO with a new Great Leader who can led us to Drug Approval and move the company forward.
    2) Possible Partnership with a MAJOR drug company that will assure the NDA will meet and exceed all the FDA standards.
    3) 60 days for the FDA (Food and Drug Administration ) to accept the application by about Q1 2016.
    4) Upon potential acceptance, FDA could also grant priority review.
    5) With priority review, six months pdufa date (Prescription Drug User Fee Act ), without, 10 months. Best guess is July to Oct 2016.
    6) EU ( European Union ) filing 6- 9 months post FDA filing. I am thinking not so long for this, say Q4 2016.
    7) ADP enrollment (019 study) complete by 2015 Q4 and data by about Q2 2016
    8) Schizophrenia maintenance trial to commence 2nd half of 2015.
    9) other, eg Autism.
    DATES ARE SUBJECT TO DEBATE OR CHANGE AND THEY DO GET DELAYED- this is not uncommon in the world of Biotech. You have to roll with the punches

  • Reply to

    ACAD- where do we go from here.

    by crecy_war_knight Mar 12, 2015 1:11 PM
    crecy_war_knight crecy_war_knight Mar 13, 2015 6:42 PM Flag

    Here my new policy...ever time I get a thumbs down, I repost it. And if you don't like it...you have a choice, don't read it or just put me on Iggy. So keep those thumbs down coming so I can re post and keep the thread going. Have a great weekend.

  • crecy_war_knight by crecy_war_knight Feb 5, 2015 12:25 PM Flag

    Their babble is typical short miss-direction. In their little mind if they F up the MB it makes them feel better. Some how they think they can influence investors. Give me a break. Our best reply is NO REPLY, PLACE ALL MORONS & SHORTS ON IGNORE . Never reply to them.

  • crecy_war_knight crecy_war_knight Mar 2, 2015 10:49 AM Flag

    This stock will continue to FALL, this is not just a faulty product issue but a MAJOR SERVICE problem. It runs throughout the company...I have seen it before with Expo...Faulty products get attention first then the service dysfunction gets exposed. Followed by BK. Get out while you can.

  • crecy_war_knight by crecy_war_knight Mar 6, 2015 3:20 PM Flag

    This is one GREAT company ACAD. I have owned shares since around $12 and never looked back. I don't try to time it, just buy & hold. This 2015 1st Q ACAD will submit a New Drug Application (NDA)for pimavanserin. This is ONE OF A KIND, FIRST IN ITS CLASS drug to treat Parkinson's Disease Psychosis (PDP). And ACAD owns the World Wide Rights to it. In the USA only there are about 1 mill patients with Parkinson's Disease and about 40% will develop psychosis (PDP). Many Parkinson's Disease patients can be cared for at home until they get psychotic then they must be placed into a so called "dementia " Skilled Nursing Facility ( called a "Sniff"). The FDA has already reviewed the Phase3 research data and given ACAD thumbs up to proceed with the New Drug Application. Currently the stock is about $38.99. I believe it is headed for $40+. The shorts have over extended themselves and have to cover 16.8 Million shares. BUY ON ANY WEAKNESS. The NDA is just around the corner so do your DD now. USA sales will be over 1.1 BILLION and European Union will be well over a Billion also. Go to ACAD web site and read everything. There are several other ongoing studies...Review the catalyst list:
    1. Filing of the NDA (New Drug Application NUPLAZID™ = pimavanserin) in the first quarter of 2015.
    2. 60 days for the FDA (Food and Drug Administration ) to accept the application.
    3. Upon potential acceptance, FDA could also grant priority review.
    4. With priority review, six months pdufa date (Prescription Drug User Fee Act ), without, 10 months.
    5. Sleep disturbance trial for PDP (Parkinson's Disease Psychosis ) patients to commence in the first half of 2015.
    6. EU ( European Union ) filing 6- 9 months post FDA filing, so around 3rd quarter.
    7. Potential top line ADP (Alzheimer's Disease Psychosis ) in fourth quarter of 2015 or around end of 2015.
    8. Schizophrenia maintenance trial to commence 2nd half of 2015.
    9. More information on NUPLAZID™ =pimavanserin, for Autism 2015-16

  • crecy_war_knight crecy_war_knight Mar 17, 2015 4:28 PM Flag

    By any chance do you wear a cape at home?

  • Reply to

    JPM Q&A mentioned Abiify is $13,000/year

    by crecy_war_knight Jan 16, 2015 10:27 AM
    crecy_war_knight crecy_war_knight Jan 16, 2015 10:54 AM Flag

    1,000,000 PD patients in the USA, of which 40% will get PDP at some point. Consider just 10% penetration - 400,000 PDP patients x 0.1 = 40,000 patients . Each at $14,600/yr, - 40,000 x 14,600 = $584,000,000/yr- Thats with only 10% of the USA market alone. And Acadia has the WORLD WIDE RIGHTS TO PIMA, FIRST IN ITS CLASS-ONE OF A KIND.

  • crecy_war_knight by crecy_war_knight Jan 4, 2015 8:51 PM Flag

    ....and all the longs have to do is HOLD, let the newbies and shorts do the heavy lifting. LMAO

    Acadia Pharmaceuticals Incorporated

    $ 31.15
    ACAD
    -0.60
    Daily Short Sale Volume
    view
    Short Interest (Shares Short)
    18,249,200
    Days To Cover (Short Interest Ratio)
    13.0
    Short Percent of Float
    23.09 %

  • crecy_war_knight crecy_war_knight Mar 17, 2015 12:22 PM Flag

    Better to remain silent and be thought a fool than to speak out and remove all doubt.

  • crecy_war_knight by crecy_war_knight Mar 22, 2015 11:32 AM Flag

    So far he just comes on the board, dumps on everyone including use LONGS and posts how he is going to report shorts to the SEC and call all his friends at the FBI. A grandiose bragger no doubt. Obviously he has a personality disorder of the narcissistic type - that will not make it here " Einstein ". These types can't shut up and have no insight to their problems. So you are either tortured all day with his repetitive rants how he rules the world or you put him on IGNORE. Hummmm big decision. So I will cast him down with the other sodomites into the Iggy Basement with all the Shorts and Bashers and Spammers. Fair well to thee oh once great cape crusader...the time has come. For I could not take another week of you Gassy Fat Mouth. Get out out the jelly or peanut butter or whatever you prefer- you're gonna need it.

  • crecy_war_knight crecy_war_knight Mar 25, 2015 12:01 AM Flag

    Reporting Owner Name / Address
    Relationships
    Director 10% Owner Officer Other
    SOLAND DANIEL B
    3611 VALLEY CENTRE DRIVE, SUITE 300
    SAN DIEGO, CA 92130 X
    Reporting Owner Name / Address
    Relationships
    Director 10% Owner Officer Other
    SOLAND DANIEL B
    3611 VALLEY CENTRE DRIVE, SUITE 300
    SAN DIEGO, CA 92130 X

    Reporting Owners
    Reporting Owner Name / Address
    Relationships
    Director 10% Owner Officer Other
    SOLAND DANIEL B
    3611 VALLEY CENTRE DRIVE, SUITE 300
    SAN DIEGO, CA 92130 X

    Stock Option (right to buy) $34.45 3/20/2015 A $15000 (1) 3/19/2025 Common Stock $15000 $0 $15000 D (ie worth $ 516,750)

  • Reply to

    $$$$$$

    by crecy_war_knight Mar 5, 2015 12:26 PM
    crecy_war_knight crecy_war_knight Mar 5, 2015 6:02 PM Flag

    I was in the 173 Airborne, Ranger unit, 75th Inf, N co. 68-69. You can read about my unit in a book titled, " Stealth Patrol...." by my buddy Bill Shanahan.

  • Reply to

    If good Alzheimer's data...

    by crecy_war_knight Jan 1, 2015 12:46 PM
    crecy_war_knight crecy_war_knight Jan 2, 2015 1:19 PM Flag

    So with 5.2 mill AD patients, @ 25% that's 1.3 mill ADP patients . Figure PIMA gets 20% penetration that's 260,000 patients, at $30/per day (conservative guess of cost per day ) that's $7.8 mill per DAY. x 365 d per year = $ 2.847 BILLION per year. WOW !

  • crecy_war_knight crecy_war_knight Jan 31, 2015 12:17 PM Flag

    believe it or not ACAD is still somewhat under the radar.

  • HAVE A GREAT YEAR ALL

  • crecy_war_knight by crecy_war_knight Jan 1, 2015 12:46 PM Flag

    As far as AD goes there are 5.2 million patients in the USA and 25-50% will get ADP. That is one heck of a lot of patients that will need treatment. So good ADP data will send this stock to ? Can you even calculate the yearly revenues ? OMG

  • crecy_war_knight crecy_war_knight Jan 5, 2015 11:56 AM Flag

    Oh don't forget he's a real genius -cut and paste anything he sees on that "reliable" place Investor Village where he is affectionately known as the "Village Idiot ". He said he is a long...sure. Most likely he is SHORT or he sold his shares and trying his best to get back in lower.............BINGO. I mean if his I.Q. was 60+ he should have know there was something wrong with that article and would have just ignored it. Par for the Village Idiot, hysterical .... " The sky is falling the sky is falling..." ROTFLMFAO.

Z
100.61-0.670(-0.66%)Mar 27 4:00 PMEDT